A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection
Introduction: It has been almost fifty years since the Towne strain was used by Plotkin and collaborators as the first vaccine candidate for cytomegalovirus (CMV). While that approach showed partial efficacy, there have been a multitude of challenges to improve on the promise of a CMV vaccine. Effor...
Main Authors: | Don Jeffrey Diamond, Corinna La Rosa, Flavia Chiuppesi, Heidi Contreras, Sanjeet Dadwal, Felix Wussow, Supriya Bautista, Ryotaro Nakamura, John A. Zaia |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-10-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2018.1526085 |
Similar Items
-
Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
by: Razonable RR
Published: (2024-09-01) -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01) -
Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01) -
Cytomegalovirus chronic retinal necrosis with ganciclovir resistance: a case report
by: Julia Xia, et al.
Published: (2024-10-01) -
Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review
by: Alyssa K. Mezochow, MD, MSc, et al.
Published: (2024-11-01)